Caribou Biosciences, Inc. Increase Decrease In Operating Lease Liability
Caribou Biosciences, Inc. (CRBU) reported Increase Decrease In Operating Lease Liability of -$572.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- Caribou Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$291.00K.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$281.00K.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$325.00K.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$389.00K.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.35M.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for fiscal 2024 was -$621.00K.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for fiscal 2023 was -$637.00K.
- Caribou Biosciences, Inc. increase decrease in operating lease liability for fiscal 2022 was -$403.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$572.00K 10-Q · filed 2026-08-13 | -$897.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$281.00K 10-Q · filed 2026-05-07 | -$606.00K derived: sum of 2 quarters · filed 2026-05-07 | -$995.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$714.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.09M derived: sum of 3 quarters · filed 2026-08-13 | -$1.35M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$761.00K derived: sum of 2 quarters · filed 2026-08-13 | -$1.02M 10-Q · filed 2025-11-12 | -$1.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$635.00K 10-Q · filed 2026-08-13 | -$789.00K derived: sum of 3 quarters · filed 2026-08-13 | -$938.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$263.00K 10-Q · filed 2026-05-07 | -$417.00K derived: sum of 2 quarters · filed 2026-05-07 | -$566.00K derived: sum of 3 quarters · filed 2026-05-07 | -$935.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$303.00K derived: sum of 2 quarters · filed 2026-03-05 | -$672.00K derived: sum of 3 quarters · filed 2026-03-05 | -$621.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$518.00K derived: sum of 2 quarters · filed 2025-11-12 | -$467.00K 10-Q · filed 2025-11-12 | -$813.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$318.00K 10-Q · filed 2025-08-12 | -$664.00K derived: sum of 3 quarters · filed 2025-08-12 | -$444.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $51.00K 10-Q · filed 2025-05-08 | -$295.00K derived: sum of 2 quarters · filed 2025-05-08 | -$75.00K derived: sum of 3 quarters · filed 2025-05-08 | -$263.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$126.00K derived: sum of 2 quarters · filed 2025-03-10 | -$314.00K derived: sum of 3 quarters · filed 2025-03-10 | -$637.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $32.00K derived: sum of 2 quarters · filed 2024-11-06 | -$291.00K 10-Q · filed 2024-11-06 | -$415.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$511.00K 10-Q · filed 2024-08-06 | -$635.00K derived: sum of 3 quarters · filed 2024-08-06 | -$732.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$323.00K 10-Q · filed 2024-05-07 | -$447.00K derived: sum of 2 quarters · filed 2024-05-07 | -$544.00K derived: sum of 3 quarters · filed 2024-05-07 | -$641.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$221.00K derived: sum of 2 quarters · filed 2024-03-11 | -$318.00K derived: sum of 3 quarters · filed 2024-03-11 | -$403.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$194.00K derived: sum of 2 quarters · filed 2023-11-07 | -$279.00K 10-Q · filed 2023-11-07 | -$257.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$182.00K 10-Q · filed 2023-08-08 | -$160.00K derived: sum of 3 quarters · filed 2023-08-08 | -$182.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$85.00K 10-Q · filed 2023-05-09 | -$63.00K derived: sum of 2 quarters · filed 2023-05-09 | -$85.00K derived: sum of 3 quarters · filed 2023-05-09 | -$85.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-09 | $0.00 10-K · filed 2023-03-09 |
| 2021-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$22.00K derived: sum of 2 quarters · filed 2022-11-08 | -$22.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |